SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?


To: John Metcalf who wrote (4257)5/7/1998 12:46:00 AM
From: Steve Fancy  Respond to of 6136
 
Many promising cancer drugs seen in the pipeline

By Maggie Fox, Health and Science Correspondent

WASHINGTON, May 6 (Reuters) - Two drugs that work together to starve out tumors in mice may show great promise but are far from being the only new weapons being developed in the fight against cancer, researchers said on Wednesday.

More than 300 new therapies are currently being tested, ranging from drugs that directly target tumors, to vaccines that turn the body's defenses against tumors, to gene therapy that aims to stop cancer at the most basic level.

biz.yahoo.com